ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan's Otsuka applies to FDA for schizophrenia smart pill

TOKYO -- Japanese drugmaker Otsuka Pharmaceutical is seeking U.S. regulatory approval to market a schizophrenia treatment that incorporates a sensor designed to ensure patients take their medicine.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more